News
-
Perivan executes successful direct mail campaign for World Cancer Research Fund's Legacy Team
March 2024
-
Symphony Environmental completes equity raising of £1.4 million and launches PrimaryBid offer to raise a further £0.5 million
March 2024
-
Perivan attend the QCA breakfast with Richard Moriarty, the CEO at the Financial Reporting Council
March 2024
-
Perivan attend the PLC Awards Dinner 2023
March 2024
-
EnSilica complete £1.1 million Secondary Fundraise
February 2024
-
Congratulations to our Investment Trust clients; AVI Global, Biotech Growth, Polar Capital Technology and Worldwide Healthcare who would have made investors an “ISA millionaire”
February 2024
-
Location Sciences completes reverse takeover of Sorted Group, share subscription and consolidation, change of name to Sorted Group Holdings and admission to AIM
February 2024
-
Prospectus published by Molten Ventures for the prior and proposed issue and admission of new ordinary shares in connection with the recommended acquisition of Forward Partners Group
February 2024
-
Combined circular and prospectus published for the £1.9 billion recommended all-share merger of LondonMetric Property and LXi REIT
February 2024
-
MicroSalt float on AIM
February 2024
-
Perivan welcomes Joe Cotterell as Chief Revenue Officer
February 2024
-
Perivan welcomes Asian Energy Impact Trust to our Annual Report portfolio
January 2024
-
Verici Dx successfully concludes the bookbuild for its placing to raise approximately £6.22 million
January 2024
-
Scheme document published for the all-share merger between Belvoir Group and the Property Franchise Group with a combined market cap of £214 million
January 2024
-
Offer document and rule 9 waiver circular published for the £5.8 million recommended all-share offer by Belluscura for TMT Acquisition
January 2024
-
2019-2023 Market Leaders for IPO Admission Document Production
January 2024
